DrugDashboards

Duloxetine Hydrochloride

Duloxetine Hydrochloride · DULOXETINE HYDROCHLORIDE 60 mg/1 · Capsule, Delayed Release · Oral · Macleods Pharmaceuticals Limited

NDC 33342-0162-07 · 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 15% over the past year, to $0.1127 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.2% of the time — roughly 2× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1127per EAinvoice-surveyed acquisition cost · Apr 23, 2025
  • Medicaid generic ceiling (FUL)$0.1288per CAPweighted avg manufacturer price $0.0736 · Mar 1, 2025114% of what pharmacies pay — higher than 67% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2Aug 2019Apr 2025$0.1127
70 price points · per EA · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$3.38
#90 count
$10.15

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2024)

$76
11 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for duloxetine hydrochloride (oral solid) in the next 90 days

6 Class I/II recall(s) in 12 months · price up 12% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA204815
TE code
AB
Approval date
Mar 23, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Duloxetine Hydrochloride (Capsule, Delayed Release)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 3, 2026
Lilly del Caribe, Inc.DULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Eli Lilly and CompanyDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Lilly del Caribe, Inc.DULOXETINE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Marksans Pharma LimitedDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Marksans Pharma LimitedDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Marksans Pharma LimitedDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Lilly del Caribe, Inc.DULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Aug 31, 2026
Aurobindo Pharma LimitedDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Aug 28, 2026
Lilly del Caribe, Inc.DULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Duloxetine Hydrochloride — NDC 33342-0162-07," retrieved September 3, 2026, https://drugdashboards.com/drug/33342016207.

Free to cite with attribution — see how the data is put together.